Achillion Pharmaceuticals, Inc. (ACHN) Posts Q3 Loss of 14c/Share
Tweet Send to a Friend
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q3 EPS of ($0.14), $0.06 better than the analyst estimate of ($0.20).
Over ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Over ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
